¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary visual area"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual deprivation
    ½Ã°¢¹ÚÅ»
  • visual discrimination
    ½Ã°¢½Äº°
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
  • visual efficiency
    ½Ã(°¢)È¿À²
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§
  • visual evoked response
    ½Ã°¢À¯¹ß¹ÝÀÀ
  • visual field
    ½Ã¾ß
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual field examination
    ½Ã¾ß°Ë»ç
  • visual hallucination
    ȯ½Ã
  • visual image
    ½Ã°¢»ó
  • visual infancy
    ¿µ¾ÆÇü½Ã°¢
  • visual inspection
    ½ÃÁø
  • visual line
    ½Ã(°¢)¼±
  • visual maturity
    ½Ã°¢¼º¼÷µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual infancy
    ¿µ¾ÆÇü½Ã°¢
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • visual line
    ½Ã°¢¼±
  • visual maturity
    ¼º¼÷½Ã°¢
  • visual memory
    ½Ã°¢±â¾ï
  • visual nystagmus
    ½Ã°¢´«¶³¸²
  • visual organ
    ½Ã°¢±â°ü
  • visual pathway
    ½Ã°¢°æ·Î
  • visual pigment
    ½Ã»ö¼Ò
  • visual purple
    ½Ã»ö¼Ò
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§
  • visual receptor
    ½Ã°¢¼ö¿ëü, °¨±¤Ã¼
  • visual red
    (¢¡rhodopsin) ½ÃÈ«, ·Îµ½½Å
  • visual evoked response
    ½Ã°¢À¯¹ß¹ÝÀÀ
  • visual seizure
    ½Ã°¢¹ßÀÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hinge area
    °æÃ¸ºÎ
  • homologous area
    »óµ¿¿µ¿ª(ßÓÔÒÖÅæ´), »ó»ç¿µ¿ª(ßÓÞÄçÐæ´).
  • posr rolandic area =postcentral a.
    ÈķѶõµå±¸·É(ý­¡­ÏµçÐ), ÈÄÁ߽ɱ¸·É(ý­ñéãý ϵçÐ).
  • posr rolandic area =postcentral a.
    ÈķѶõµå
  • posr rolandic area =postcentral a.
    ÈķѶõµå±¸·É(ý­¡­ÏµçÐ), ÈÄÁ߽ɱ¸·É(ý­ñéãý ϵçÐ).
  • posterior hypothalamic area
    ÈĽûóÇϺΠ¿µ¿ª.
  • posterior intercondylar area
    µÚÀ¶±â»çÀ̱¸¿ª
  • premamillary area
    ÀüÀ¯µÎü¿µ¿ª.
  • premotor area
    Àü¿îµ¿¿µ¿ª(îñê¡ÔÑçÐæ´).
  • preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
  • pretectal area
    µ¤°³¾Õ±¸¿ª
  • primary sensory area
    ÀÏÂ÷°¨°¢¿µ¿ª (¡­çÐæ´).
  • pulmonary area
    Æó¿µ¿ª, Æó¾ß(øËå¯).
  • pupil area
    µ¿°øºÎÀ§
  • pupillary area =p. zone
    µ¿°ø¾ß(ÔÚÍîå¯).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual directive line
    ½Ã¹æÇâ¼±(ãÊÛ°ú¾àÊ).
  • visual discrimination
    ½Ã°¢½Äº°
  • visual discriminatory acuity
    ½Ã°¢½Äº°µµ(ãÊÊÆãÛܬöô).
  • visual disorder =v. disturbance
    ½Ã°¢Àå¾Ö(¡­î¡äô)
  • visual disturbance
    ½Ã°¢Àå¾Ö.
  • visual efficiency
    ½ÃÈ¿À².
  • visual evoked potential
    ½ÃÀ¯¹ßÀüÀ§
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§.
  • visual evoked response
    ½ÃÀ¯¹ß¹ÝÀÀ
  • visual fatigue
    ½Ã°¢ÇÇ·Î
  • visual field
    ½Ã¾ß(ãÊå¯)
  • visual field
    ½Ã¾ß(ãÊå¯).
  • visual field
    ½Ã¾ß(ãÊå¯)
  • visual field defect
    ½Ã¾ß°á¼Õ(¡­ÌÀáß).
  • visual field defect
    ½Ã¾ß°á¼Õ(¡­ÌÀáß)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SGE secondary generalized epilepsy
SHO secondary hypertrophic osteoarthropathy; Senior House Officer
SHP Schonlein-Henoch purpura; secondary hyperparathyroidism; state health plan
sHPT secondary hyperparathyroidism
SIMS secondary ion mass spectroscopy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LVF Left visual field
PRVEP Pattern Reversal Visual Evoked Potential
PSVEP Pattern Shift Visual Evoked Potentials
PVEP Pattern Visual Evoked Potential
pVEP Pattern reversal visual evoked potentials
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • area cochleae
    ¿Í¿ì ¿µ¿ª
    ¿Í¿ìÀúÀÇ ±Ù¹æ¿¡¼­ ³»À̵µÀú ÇϺÎÀÇ ¾ÕºÎºÐ.
  • area cribrosa
    ü±¸¿ª
  • area lunata
    ¿ù»ó ¿µ¿ª
    ¼Ò³ú ¹Ý±¸ÀÇ ÈĹݿù ¼Ò¿±À¸·Î¼­ ÈÄ¿ù¿±ÀÇ ¾Õ¿¡ ÀÖ´Ù.
  • area nervi facialis
    ¾È¸é ½Å°æ ¿µ¿ª
    ¾È¸é ½Å°æÀÌ ¾È¸é ½Å°æ °ü¿¡ µé¾î°¡´Â ³»À̵µÀúÀÇ ºÎºÐ.
  • area of body surface
    üǥ¸éÀû
  • area pellucida
    Åõ¸í ±¸¿ª, Åõ¸íºÎ
    »õÀÇ ¾Ë¿¡¼­ ³ªÅ¸³ª´Â ¹è¹Ý ¿Ü°ûÀÇ Åõ¸íÇÑ ºÎºÐ.
  • area sampling
    Áö¿ª ÃßÃâ¹ý
  • area subcallosa
    ³ú·®ÇÏ ¿µ¿ª
    ¾çÇÏȸÀÇ ¹Ù·Î ¾Õ ´ë³ú ¹Ý±¸ ³»Ãø ¸é¿¡ ÀÖ´Â ÀÛÀº ºÎºÐ.
  • area under the concentration-time curve
    Ç÷Áß ³óµµ °î¼±ÇÏ ¸éÀû, Ç÷Áß ¾à¹° ³óµµ °î¼±ÇÏ ¸éÀû
  • area vestibularis
    ÀüÁ¤ ½Å°æ ¿µ¿ª
    Á¦ 4³ú½Ç ±âÀúºÎÀÇ »ï°¢ ¿ÜÃøºÎ¿Í »ï°¢ Á¤Áߺημ­ ±× À§¸¦ Á¦ 4³ú½ÇÀÇ ¼öÁ¶°¡ ÅëÇÑ´Ù.
  • area vestibularis superior
    »óÀüÁ¤ ¿µ¿ª
    ³»À̵µÀúÀÇ »óºÎ.
  • association area
    ¿¬ÇÕ ±¸¿ª, ¿¬ÇÕ¾ß, ¿¬ÇÕ ¿µ¿ª
    ´ë³ú ÇÇÁúÀÇ °¢¸éÀ¸·Î¼­ ³ú·®°ú ³ú¹Ý±¸ÀÇ ¹éÁúÀ» Åë°úÇÏ´Â ¸¹Àº ¼¶À¯¿¡ ÀÇÇØ ¿¬°áµÇ°í ½Ã»ó°úµµ ¿¬°áµÇ¾î ÀÖ´Ù. ±â¾ï°ú ÇнÀ µî¿¡ °ü¿©ÇÑ´Ù.
  • auscultatory area
    ûÁø ºÎÀ§
  • axial area
    Ãà ¿µ¿ª
    »çÁöÀÇ Ç¥¸éÀ¸·Î¼­ ÇǺο¡ ºÐÆ÷Çϴ ôÃ߽Ű氣ÀÇ ¿­°ø.
  • basal seat area
    ±âÀúºÎ
    ±¸°­³» ±¸Á¶·Î¼­ ÀÇÄ¡¸¦ ÁöÁöÇÒ ¼ö ÀÖ´Â ºÎÀ§.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
secondary buffer See: Hamburger's law.
(05 Mar 2000)
secondary calcium phosphate CaHPO4-2H2O;used as a calcium and phosphorus dietary supplement.
Synonym: calcium monohydrogen phosphate, secondary calcium phosphate.
(05 Mar 2000)
secondary carcinoma <tumour> A carcinoma that has appeared in a region remote from its site of origin, as in metastasis.
Synonym: secondary carcinoma.
(05 Mar 2000)
secondary cardiomyopathy Disease that affects the myocardium secondarily to systemic disease, infection, or metabolic disease.
(05 Mar 2000)
secondary caries Caries of enamel beginning at the dento-enamel junction due to a rapid lateral spread of decay from the original decay.
(05 Mar 2000)
secondary cataract A cataract that accompanies or follows some other eye disease such as uveitis.
Synonym: complicated cataract.
A cataract occurring in the retained lens or capsule after a cataract extraction.
Synonym: aftercataract.
(05 Mar 2000)
secondary cementum Cementum that forms on the root surface after eruption; it contains cementocytes.
(05 Mar 2000)
secondary centre of ossification This is the centre of bone formation appearing later than the punctum ossificationis primarium, usually in epiphysis.
Synonym: punctum ossificationis secundarium, secondary point of ossification.
(05 Mar 2000)
secondary choana The definitive choana opening into the nasopharynx, after the nasal chambers have been lengthened by the formation of the secondary palate.
Synonym: internal nostril.
(05 Mar 2000)
secondary coccidioidomycosis Progressive or disseminated extrapulmonary granulomatous lesions following primary coccidioidomycosis.
Synonym: coccidioidal granuloma.
(05 Mar 2000)
secondary constriction A subsidiary narrowing of the chromosome associated in some cases with satellites.
(05 Mar 2000)
secondary degeneration <medicine> A form of degeneration occurring in nerve fibres as a result of their division; so called from Dr. Waller, who published an account of it in 1850.
Source: Websters Dictionary
(01 Mar 1998)
secondary dementia Chronic dementia following and due to a psychosis or some other underlying disease process.
Senile dementia, dementia of Alzheimer's disease developing after age 65.
Toxic dementia, dementia caused by an exogenous agent.
(05 Mar 2000)
secondary dentin Dentin formed by normal pulp function after root end formation is complete.
(05 Mar 2000)
secondary dentition One of the 32 teeth belonging to the second or permanent dentition; eruption of the permanent teeth begins from the fifth to the seventh year, and is not completed until the seventeenth to the twenty-third year, when the last of the wisdom teeth appears.
Synonym: dens permanens, dens succedaneus, second tooth, secondary dentition, succedaneous dentition, succedaneous tooth.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á